We are live on ! Find out more
BRLI

BIO-REFERENCE LABS INC-NEW-
BRLI

Delisted

BRLI was delisted on the 19th of August, 2015.

168 hedge funds and large institutions have $673M invested in BIO-REFERENCE LABS INC-NEW- in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 65 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 168168 (0)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

12% less capital invested

Capital invested by funds: $760M → $673M (-$87.6M)

15% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 65

61% less call options, than puts

Call options by funds: $5.91M | Put options by funds: $15.3M

Holders
168
Holders Change
Holders Change %
0%
% of All Funds
4.87%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
15
Increased
55
Reduced
65
Closed
15
Calls
$5.91M
Puts
$15.3M
Net Calls
-$9.42M
Net Calls Change
-$6.02M
Name Holding Trade Value Shares
Change
Change in
Stake
Neuberger Berman Group
26
Neuberger Berman Group
New York
$8.13M -$44.1K -1,448 -0.5%
RA
27
Royce & Associates
New York
$7.88M -$714K -23,434 -8%
WF
28
Welch & Forbes
Massachusetts
$6.83M -$263K -8,640 -3%
SGCIA
29
Smith Graham & Co Investment Advisors
Texas
$6.61M -$202K -6,630 -3%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$5.34M +$1.94M +63,667 +50%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$4.94M +$152K +4,996 +3%
Principal Financial Group
32
Principal Financial Group
Iowa
$4.17M -$51.7K -1,699 -1%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$4.04M +$69.3K +2,274 +2%
Morgan Stanley
34
Morgan Stanley
New York
$3.98M +$2.07M +67,950 +92%
Wells Fargo
35
Wells Fargo
California
$3.94M +$207K +6,782 +5%
GF
36
Gabelli Funds
New York
$3.91M +$1.48M +48,700 +54%
UBS AM
37
UBS AM
Illinois
$3.7M -$150K -4,917 -4%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$3.58M
MAA
39
Managed Account Advisors
New Jersey
$3.25M -$215K -7,049 -6%
WA
40
Wasatch Advisors
Utah
$3.24M +$518K +17,001 +17%
EAM
41
EverPoint Asset Management
Connecticut
$3.23M -$335K -11,000 -9%
TM
42
Tikvah Management
North Carolina
$3.23M
Invesco
43
Invesco
Georgia
$3.16M +$284K +9,315 +9%
Ameriprise
44
Ameriprise
Minnesota
$3.02M +$130K +4,267 +4%
TCIM
45
TIAA CREF Investment Management
New York
$2.99M -$56.3K -1,848 -2%
NFA
46
Nationwide Fund Advisors
Ohio
$2.71M -$877K -28,791 -23%
LSV Asset Management
47
LSV Asset Management
Illinois
$2.63M -$3.34M -109,600 -54%
Millennium Management
48
Millennium Management
New York
$2.39M +$2.59M +85,123 New
SCM
49
Sterling Capital Management
North Carolina
$2.31M -$67.8K -2,225 -3%
BIM
50
BlackRock Investment Management
Delaware
$2.3M +$8.01K +263 +0.3%

BRLI Hedge Fund Activity: Q3 2014 in Review

168 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q3 2014, worth a combined $673M — down 12% from $760M a quarter earlier.

Fund positioning in BRLI was balanced in Q3 2014: 15 funds opened new positions, 15 closed out, 55 added to existing stakes and 65 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.26M. The largest seller was Epoch Investment Partners, cutting an estimated $10.8M.

  • 168 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $673M of BIO-REFERENCE LABS INC-NEW- stock for Q3 2014, down 12% quarter-over-quarter.
  • 15 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q3 2014 and 15 closed out, a net change of 0 holders.
  • The largest BIO-REFERENCE LABS INC-NEW- buyer in Q3 2014 was Northern Trust, an estimated $6.26M added.
  • The largest BIO-REFERENCE LABS INC-NEW- seller in Q3 2014 was Epoch Investment Partners, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2014.